Wednesday, January 19, 2022 8:44:48 AM
Principal Financial Group Inc. Acquires 25,684 Shares of Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical logoPrincipal Financial Group Inc. grew its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) by 2.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,057,611 shares of the specialty pharmaceutical company’s stock after acquiring an additional 25,684 shares during the period. Principal Financial Group Inc. owned about 3.06% of Collegium Pharmaceutical worth $20,878,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also modified their holdings of COLL. Peregrine Capital Management LLC bought a new stake in shares of Collegium Pharmaceutical during the 3rd quarter valued at $13,464,000. Dimensional Fund Advisors LP grew its position in shares of Collegium Pharmaceutical by 33.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 775,908 shares of the specialty pharmaceutical company’s stock valued at $18,344,000 after acquiring an additional 193,468 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Collegium Pharmaceutical by 29.4% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 832,554 shares of the specialty pharmaceutical company’s stock valued at $19,682,000 after acquiring an additional 189,232 shares during the period. Federated Hermes Inc. boosted its holdings in Collegium Pharmaceutical by 76,168.4% in the 2nd quarter. Federated Hermes Inc. now owns 171,604 shares of the specialty pharmaceutical company’s stock worth $4,057,000 after buying an additional 171,379 shares during the period. Finally, LSV Asset Management bought a new position in Collegium Pharmaceutical in the 3rd quarter worth $2,899,000.
https://etfdailynews.com/news/principal-financial-group-inc-acquires-25684-shares-of-collegium-pharmaceutical-inc-nasdaqcoll/
Recent COLL News
- Collegium to Report First Quarter 2024 Financial Results on May 9, 2024 • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026 • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:26:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 10:24:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 09:39:36 PM
- Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results • GlobeNewswire Inc. • 02/22/2024 09:09:56 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 09:03:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:15:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:14:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:14:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:14:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:13:23 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:04:28 PM
- Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024 • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:19:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/16/2024 09:20:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 01:03:11 PM
- Collegium Provides 2024 Financial Guidance • GlobeNewswire Inc. • 01/03/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:36:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/21/2023 09:15:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:51:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/20/2023 09:28:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/19/2023 09:13:16 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM